Article

Detection of mutated KRAS, TP53, CDK2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing

2025-01-28

Abstract excerpt

<title>Abstract</title> <p>Pancreatic adenocarcinoma (PDAC) is one of the most lethal cancer types worldwide, with early diagnosis being challenging due to nonspecific symptoms that are often noticed only when the tumor reaches a large size. Liquid biopsy has emerged as a promising technology for cancer detection, where the identification of tumoral cell-free DNA (cfDNA) using sensitive methodologies can identify...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 10c027c2-4eab-5efa-a215-fad0e21364d9
DOI: 10.21203/rs.3.rs-5850874/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Detection of mutated KRAS, TP53, CDK2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencingDOI 10.21203/rs.3.rs-5850874/v1Read

Detection of mutated KRAS, TP53, CDKN2A, and SMAD4 in tumor cell-free DNA of Brazilian pancreatic adenocarcinoma patients using next-generation sequencing.Semantic proximity Read

Current status of molecular diagnostic approaches using liquid biopsy.Semantic proximity Read

Clinical Utility of Circulating Tumor DNA for Molecular Assessment and Precision Medicine in Pancreatic Cancer.Semantic proximity Read

Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinomaSemantic proximity Read

Clinical utility of circulating tumor DNA for molecular assessment in pancreatic cancer.Semantic proximity Read

Next-Generation Sequencing in Pancreatic CancerSemantic proximity Read

Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlationsSemantic proximity Read

Pancreatic circulating tumor cell detection by targeted single-cell next-generation sequencing.Semantic proximity Read

Cell free DNA in patients with pancreatic adenocarcinoma: clinicopathologic correlations.Semantic proximity Read

Detection of mutant KRAS and TP53 DNA in circulating exosomes from healthy individuals and patients with pancreatic cancer.Semantic proximity Read

Somatic Mutation Detection in Tumor Tissue and Matched Cell-Free DNA Using PCR-Based Methods in Pancreatic Cancer Patients Undergoing Upfront ResectionSemantic proximity Read

High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.Semantic proximity Read